MetaVia Inc. (MTVA) Stock Price

1.305 ▼ -0.195 (-13.00%)
Open: 1.31 Vol: 37.5K Day's range: 1.11 - 1.34 Sep 16, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MTVA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 1.26▲ 1.22▲ 1.23▲ 0.97▲ 0.79▲
MA10 1.23▲ 1.22▲ 1.28▲ 0.83▲ 0.72▲
MA20 1.22▲ 1.20▲ 0.99▲ 0.73▲ 0.71▲
MA50 1.22▲ 0.88▲ 0.79▲ 0.69▲ N/A    
MA100 1.24▲ 0.76▲ 0.72▲ 0.70▲ N/A    
MA200 0.94▲ 0.74▲ 0.71▲ N/A     N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.012▲ -0.017▼ 0.017▲ 0.073▲ 0.103▲
RSI 73.547▲ 65.886▲ 69.599▲ 77.211▲ 62.222▲
STOCH 94.688▲ 31.252     47.353     71.057     57.029    
WILL %R -21.875▲ -67.769     -39.810     -38.214     -36.180    
CCI 239.875▲ 38.810     49.928     221.656▲ 465.443▲
Latest Filters Detected On MTVA
▼ GAP $MTVA Open Gap Down %5 Set Alert
▼ GAP $MTVA Open Gap Down %3 Set Alert
▼ GAP $MTVA Open Gap Down %2 Set Alert
CDL $MTVA Harami Candlestick Pattern Detected Set Alert
CDL $MTVA Doji Candlestick Pattern Detected Set Alert
MetaVia Inc. News
MetaVia Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Thursday, August 07, 2025 05:31 AM
$17.6 Million in Cash at End of Second Quarter is E xpected to Fund the Company Into 2026 CAMBRIDGE, Mass., Aug. 7, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology ...
MetaVia Extends 48 mg MAD Portion of Its Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity to 8 Weeks and Announces Fifth Weekly Dose in First Patient
Tuesday, August 05, 2025 10:31 PM
CAMBRIDGE, Mass., Aug. 6, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has ...
MetaVia Announces AI-Driven Collaboration with Syntekabio to Explore Additional Indications for DA-1241
Monday, August 04, 2025 05:31 AM
CAMBRIDGE, Mass., Aug. 4, 2025 /PRNewswire/ --MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a research ...
MTVA historical stock data
date open high low close volume
16/09/25 1.31 1.34 1.11 1.305 5,337,944
15/09/25 0.687 1.7299 0.6818 1.50 85,918,908
12/09/25 0.698 0.70 0.684 0.696 29,000
11/09/25 0.69 0.6999 0.6788 0.6837 43,571
10/09/25 0.68 0.685 0.661 0.679 44,100
09/09/25 0.68 0.6898 0.67 0.678 29,063
08/09/25 0.71 0.71 0.6879 0.6901 56,892
05/09/25 0.699 0.70 0.68 0.6899 27,615
04/09/25 0.663 0.69 0.663 0.687 76,700
03/09/25 0.65 0.699 0.65 0.67 91,400
Quote Details
52wk Low:0.556
52wk High:2.75
Vol:37.5K
Avg Vol(3m):32.1M
1Y Chng:+0.00%
1M Chng:+117.50%
Add to Watch List
More Information
Index US Composite
Market Cap. 14.42M